GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1823 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.5579 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2C, KCNH2, KDR, MET, PPARA, SRC, TNKS, TNKS2, XDH |
11.5624 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
ADRB2, AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CA9, CDK6, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, PPARA, RORC, SRC, TYR |
9.18422 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRB2, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, PPARA, RORC, SRC, TYR |
8.86808 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA1A, ADRB2, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, PPARA, RORC, SRC, TYR |
8.72046 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADRA1A, AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CDK6, CHRNA3, CHRNA7, CNR2, CYP1A1, CYP1B1, FABP3, HSD11B2, HTR2C, KCNH2, KDR, SRC |
8.63445 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, RORC, SRC, TYR |
7.85138 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, SRC |
7.5664 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, GLO1, HTR2C, PIM1, PPARA, TYR, XDH |
7.46347 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
7.18877 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM2, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, KDR, MET, PIM1, PPARA, RORC, SRC, TNKS2, TOP2A, TYR |
7.16704 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, F10, F2, F3, FLT3, HCAR2, HTR2C, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
7.12662 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, F10, F2, F3, FLT3, HCAR2, HTR2C, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
7.12222 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.01986 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
6.72136 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRB2, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC |
6.65213 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.65009 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
6.5742 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.30548 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ADRB2, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CDK6, CHRM2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F10, F2, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, PPARA, PTPN1, RORC, SRC, TOP2A, TYR |
6.30548 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
6.00559 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.00559 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AXL, BCL2, CHRNA7, CYP1B1, F10, F2, F3, FLT3, HTR2C, KDR, MET, PTPN1, SRC, XDH |
5.95117 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, FABP4, FLT3, HTR2C, KCNH2, MET, SRC |
5.87293 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F2, F3, FABP4, HSD11B2, HSD17B2, HTR2C, IGF1R, KCNH2, MET, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
5.855 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
5.77863 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, CHRNA3 |
5.63668 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2C |
5.60402 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, RORC, SRC, TYR |
5.3968 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
5.2482 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TOP2A, XDH |
5.18266 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, F10, F2, F3, FLT3, HTR2C, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
5.10331 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, F2, HCAR2, HTR2C, KDR, SRC, TNKS, TNKS2 |
5.04817 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
4.94999 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CHRNA7, CNR2, CYP1A1, CYP1B1, KDR, SRC |
4.92343 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, ADRA1B, ADRA1D, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM2, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FLT3, GBA2, HSD11B1, HSD17B2, KDR, PIM1, PPARA, RORC, SRC, TYR |
4.90209 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
4.86934 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
4.75751 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA1D, AKR1B1, BCL2, CDC25B, CDK6, CHRNA7, CSNK2A1, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, FLT3, IGF1R, KDR, PIM1, SRC, XDH |
4.61836 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB2, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.50101 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TOP2A, XDH |
4.50101 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, F10, F2, F3, FLT3, HTR2C, IGF1R, KDR, MET, PTPN1, SRC, XDH |
4.50101 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.47119 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR2 |
4.42236 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.30887 |
[BP] GO:0006811 |
None
|
ABCB1, ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, FABP3, HTR2C, KCNH2, PPARA |
4.22847 |
[BP] GO:0001994 |
None
|
ADRA1A, ADRA1B, ADRA1D |
4.22847 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.22847 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2C, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.17901 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.08611 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA1B, ADRA1D, AKR1B1, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, FABP4, HTR2C, KCNH2, MET |
4.05987 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB2, APEX1, AXL, BCL2, CA2, CA7, CDK6, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, F10, F2, F3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PPARA, PTPN1, SRC |
3.99966 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, PIM1, PTPN1, SRC, TOP2A, XDH |
3.97746 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
3.91406 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
3.91406 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB2, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.8769 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HTR2C, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.8769 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, BCL2, CA2, CDK6, CHRM2, CHRNA3, CHRNA7, CYP1B1, ESR1, ESRRA, ESRRB, F2, F3, HCAR2, HTR2C, KCNH2, KDR, MET, PIM1, SRC, TNKS2, XDH |
3.87464 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.86558 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
3.86323 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2C, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.86323 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESRRA, F10, F2, F3, FABP4, FLT3, HTR2C, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
3.86323 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AURKB, AXL, BCL2, CDK6, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F10, F2, F3, FABP4, FLT3, HTR2C, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
3.78804 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
3.78804 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HTR2C, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.76161 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, ADRA1B, ADRA1D, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
3.74593 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
3.72961 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA1B, ADRA1D, CHRM2, ESR1, HTR2C |
3.71272 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
3.70951 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, F2, FABP3, FLT3, HCAR2, HTR2C, PPARA, RORC, SRC |
3.69168 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, FABP3, HTR2C, KCNH2 |
3.66243 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, F2, HTR2C, KDR, SRC |
3.65092 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, SRC |
3.65092 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, ADRB2, CA2, CA7, CHRNA3, CHRNA7, CNR2 |
3.45285 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, ADRB2, CA2, CA7, CHRNA3, CHRNA7, CNR2 |
3.45285 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FABP4, FLT3, HTR2C, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.45285 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, F2, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
3.45256 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.45254 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
3.45254 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, ADRB2, BCL2, CHRNA3, CHRNA7, CNR2, KCNH2, KDR, SRC |
3.36601 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, CHRNA3 |
3.35473 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA1B, ADRB2, CHRNA7, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
3.27841 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.26789 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.24965 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, CHRNA3, HCAR2, HTR2C, KCNH2 |
3.22839 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FABP4, FLT3, HTR2C, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.19418 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESRRB, F2, FABP3, FABP4, FLT3, HTR2C, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.14813 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA12, CA2, CA7, CHRNA7, ESR1, F2, HTR2C, KCNH2 |
3.143 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA1D, AKR1B1, BCL2, CDC25B, CDK6, CHRNA7, CSNK2A1, ESR1, F2, F3, FLT3, IGF1R, KDR, PIM1 |
3.14272 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.11083 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, CNR2 |
3.04067 |
[BP] GO:1901652 |
response to peptide
|
ADRB2, AKR1B1, APEX1, CHRNA7, FABP3, HSD11B2, IGF1R, PPARA, SRC |
3.01558 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.01558 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.01558 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, FLT3, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.01487 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, ADRB2, CA2, CA7, CHRNA7 |
3.01487 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRB2, AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, RORC, SRC |
2.99904 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2C, PPARA, SRC |
2.98341 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.94121 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.92942 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.92513 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TNKS |
2.90806 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRB2, AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, RORC, SRC |
2.89636 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.89342 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC |
2.8438 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADRB2, AKR1B1, APEX1, CHRNA3, CHRNA7, CNR2, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TYR |
2.8438 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, F2, FABP4, FLT3, HTR2C, IGF1R, KDR, PTPN1, SRC, XDH |
2.8438 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
2.83668 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KCNH2, KDR, SRC |
2.83396 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, RORC, SRC, TOP2A |
2.81459 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, FLT3, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.75999 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA1B, ADRB2, CHRNA7, FLT3, HTR2C, IGF1R, KDR, PTPN1, SRC, XDH |
2.73759 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D |
2.72541 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.71997 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.71997 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.71997 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRA1A, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, ESR1, ESR2, F2, F3, FLT3, MET, PTPN1, SRC, TNKS, XDH |
2.69073 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HTR2C, SRC, TNKS, TNKS2 |
2.66152 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, PIM1, PTPN1, SRC |
2.63259 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.63259 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRB2, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR2C, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.60067 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, F2, FLT3, IGF1R, KDR, MET, SRC, TNKS, TOP2A |
2.59218 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2C, SRC |
2.59211 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, HTR2C, KCNH2 |
2.58855 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, ESR1, F2, F3, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
2.58368 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, F2, HCAR2, TNKS, TNKS2 |
2.56766 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRB2, AURKB, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS |
2.56047 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, CHRNA3 |
2.55317 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADRB2, AKR1B1, APEX1, CHRNA7, CNR2, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TYR |
2.55317 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
2.55317 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
2.54279 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, SRC |
2.52884 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2 |
2.51548 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, SRC |
2.49886 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.49544 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CHRM2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HCAR2, HSD17B1, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.49124 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA1B, ADRB2, AKR1B1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, ESR1, ESR2, F10, F2, F3, FLT3, HTR2C, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
2.47083 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.47083 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, HSD11B2 |
2.47083 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.43086 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, F2, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
2.42734 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA1B, ADRB2, BCL2, CDC25B, CHRNA3, CHRNA7, ESR1, F2, F3, FLT3, HTR2C, KDR, PTPN1, SRC, XDH |
2.37911 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, BCL2, CA2, CHRNA7, CYP1B1, ESRRB, F2, F3, HCAR2, KDR, MET, PIM1, SRC |
2.37059 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.36407 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.34805 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.34805 |
[BP] GO:1905144 |
None
|
CHRNA3, CHRNA7 |
2.34805 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADRA1D, ADRB2, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.33135 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRB2, AURKB, CDC25B, CHRNA3, CHRNA7, F2, FLT3, PTPN1, SRC, TNKS |
2.32392 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.31385 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, HTR2C |
2.31064 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.31009 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
2.30557 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SRC |
2.29917 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CHRNA7, CYP1A1, HSD11B2, PPARA, SRC |
2.27792 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.27102 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
2.27102 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, F2, PPARA |
2.25154 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA1A, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, F2, F3, FABP4, FLT3, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS, XDH |
2.24754 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, ESR1, F2, F3, FLT3, PTPN1, SRC, TNKS, XDH |
2.24669 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CA2, CA7, CHRNA7, ESR1, F2, HTR2C |
2.24667 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CHRNA7, CYP1A1, HSD11B2, PPARA, SRC |
2.21699 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.20556 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRB2, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CNR2, CSNK2A1, ESR1, F2, F3, FABP4, FLT3, IGF1R, PTPN1, SRC, TNKS, XDH |
2.18865 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.17899 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.1724 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, F2, PPARA |
2.17051 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, PIM1, PTPN1, SRC |
2.16428 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.15665 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.15207 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.15207 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRB2, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, PTPN1, RORC, SRC, TOP2A |
2.13378 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.13066 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TNKS |
2.12808 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.12396 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.12396 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.12396 |
[BP] GO:0095500 |
None
|
CHRM2, CHRNA3, CHRNA7 |
2.1213 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.1213 |
[BP] GO:1903831 |
None
|
CHRM2, CHRNA3, CHRNA7 |
2.1213 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, HTR2C |
2.11603 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.11437 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB2, AURKB, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, HTR2C, IGF1R, KDR, MET, PPARA, RORC, SRC, TNKS, TNKS2, TOP2A |
2.10934 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRB2, AURKB, CDC25B, CHRNA3, CHRNA7, F2, FABP4, FLT3, IGF1R, PTPN1, SRC, TNKS |
2.10704 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, CHRM2, KCNH2 |
2.08821 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.0778 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB2, BCL2, CDK6, CNR2, CYP19A1, ESR1, ESR2, F2, IGF1R, MET, PPARA, PTPN1, SRC, XDH |
2.0778 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.0778 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2 |
2.0611 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2 |
2.0611 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CHRNA7, CYP1A1, HSD11B2, PPARA, SRC |
2.04238 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, HTR2C |
2.04209 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, ADRA1B, ADRA1D, BCL2, CHRNA7, ESR1, F2, HTR2C |
2.00798 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.00798 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA1B, ADRA1D, ADRB2, SRC |
2.00798 |
[BP] GO:0043393 |
regulation of protein binding
|
ADRB2, AURKB, BCL2, MET, PPARA, SRC |
2.00798 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CHRNA3, CHRNA7, CNR2, CSNK2A1, ESR1, F10, F2, F3, FLT3, GBA2, GLO1, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC |
3.86217 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CHRNA3, CHRNA7, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F10, F2, F3, FLT3, FUT7, GBA2, GLO1, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR |
3.29691 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CA2, CA4, CA9, CHRM2, CHRNA3, CHRNA7, CNR2, F10, F2, F3, FLT3, HTR2C, IGF1R, KCNH2, KDR, MET, SRC |
2.99775 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CHRNA3, CHRNA7, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F10, F2, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR2C, IGF1R, KCNH2, KDR, MET, PTPN1, SRC, TYR |
2.66795 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CA4, CHRM2, CNR2, F10, F3, FLT3, HTR2C, IGF1R, KDR, MET |
2.56475 |
[CC] GO:0044853 |
plasma membrane raft
|
ADRA1A, ADRA1B, CHRNA3, CHRNA7, SRC |
2.55317 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.25526 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, ADRA1A, ADRA1B, ADRB2, CA2, CA4, CA9, CHRM2, CHRNA3, CHRNA7, MET, SRC |
2.22133 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
19.5943 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
12.6028 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.5579 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.4801 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
9.38708 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HTR2C, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
9.09809 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, F2, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
9.03493 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRM2, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
8.67781 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CDK6, CHRM2, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
8.05687 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRM2, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.59276 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, PPARA, PTPN1, RORC, TNKS |
7.12222 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRM2, CHRNA3, CHRNA7, CNR2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, HTR2C, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.82696 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, GLO1, HTR2C, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.51448 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.9342 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.9342 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.88757 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.79797 |
[MF] GO:0004937 |
None
|
ADRA1A, ADRA1B, ADRA1D |
4.72191 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.63458 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2, CHRM2, HTR2C |
4.60943 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.52515 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F2, GLO1, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.47501 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
4.27851 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CDK6, CHRM2, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HTR2C, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
4.27851 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA1B, ADRA1D, ADRB2 |
4.05415 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRM2, CHRNA3, CHRNA7, CNR2, F3, FLT3, HCAR2, HTR2C, IGF1R, KDR, MET |
3.86558 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA1B, ADRA1D, ADRB2, AXL, CHRM2, CHRNA3, CHRNA7, CNR2, F3, FLT3, HCAR2, HTR2C, IGF1R, KDR, MET |
3.86558 |
[MF] GO:0004936 |
None
|
ADRA1A, ADRA1B, ADRA1D |
3.6685 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.50614 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.36601 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.32223 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.26789 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.20977 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.15786 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.04017 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.78246 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.71997 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.71997 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRNA3, CHRNA7, HSD17B1, IGF1R |
2.66042 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.56475 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.54279 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.48352 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.47706 |
[MF] GO:0042166 |
None
|
ACHE, CHRNA3, CHRNA7 |
2.43086 |
[MF] GO:0015464 |
None
|
CHRM2, CHRNA3, CHRNA7 |
2.36407 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRNA3, CHRNA7, HTR2C |
2.34024 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.27102 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.23279 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRB2, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, PIM1, PPARA, PTPN1, SRC |
2.18865 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, SRC, XDH |
2.15077 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.12396 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.00798 |